Cargando…
Not All Are Lost: Interrupted Laboratory Monitoring, Early Death, and Loss to Follow-Up (LTFU) in a Large South African Treatment Program
BACKGROUND: Many HIV treatment programs in resource-limited settings are plagued by high rates of loss to follow-up (LTFU). Most studies have not distinguished between those who briefly interrupt, but return to care, and those more chronically lost to follow-up. METHODS: We conducted a retrospective...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3299719/ https://www.ncbi.nlm.nih.gov/pubmed/22427925 http://dx.doi.org/10.1371/journal.pone.0032993 |
_version_ | 1782226156757450752 |
---|---|
author | Ahonkhai, Aima A. Noubary, Farzad Munro, Alison Stark, Ruth Wilke, Marisa Freedberg, Kenneth A. Wood, Robin Losina, Elena |
author_facet | Ahonkhai, Aima A. Noubary, Farzad Munro, Alison Stark, Ruth Wilke, Marisa Freedberg, Kenneth A. Wood, Robin Losina, Elena |
author_sort | Ahonkhai, Aima A. |
collection | PubMed |
description | BACKGROUND: Many HIV treatment programs in resource-limited settings are plagued by high rates of loss to follow-up (LTFU). Most studies have not distinguished between those who briefly interrupt, but return to care, and those more chronically lost to follow-up. METHODS: We conducted a retrospective cohort study of 11,397 adults initiating antiretroviral therapy (ART) in 71 Southern African Catholic Bishops Conference/Catholic Relief Services HIV treatment clinics between January 2004 and December 2008. We distinguished among patients with early death, within the first 7 months on ART; patients with interruptions in laboratory monitoring (ILM), defined as missing visits in the first 7 months on ART, but returning to care by 12 months; and those LTFU, defined as missing all follow-up visits in the first 12 months on ART. We used multilevel logistic regression models to determine patient and clinic-level characteristics associated with these outcomes. RESULTS: In the first year on ART, 60% of patients remained in care, 30% missed laboratory visits, and 10% suffered early death. Of the 3,194 patients who missed laboratory visits, 40% had ILM, resuming care by 12 months. After 12 months on ART, patients with ILM had a 30% increase in detectable viremia compared to those who remained in care. Risk of LTFU decreased with increasing enrollment year, and was lowest for patients who enrolled in 2008 compared to 2004 [OR 0.49, 95%CI 0.39–0.62]. CONCLUSIONS: In a large community-based cohort in South Africa, nearly 30% of patients miss follow-up visits for CD4 monitoring in the first year after starting ART. Of those, 40% have ILM but return to clinic with worse virologic outcomes than those who remain in care. The risk of chronic LTFU decreased with enrollment year. As ART availability increases, interruptions in care may become more common, and should be accounted for in addressing program LTFU. |
format | Online Article Text |
id | pubmed-3299719 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-32997192012-03-16 Not All Are Lost: Interrupted Laboratory Monitoring, Early Death, and Loss to Follow-Up (LTFU) in a Large South African Treatment Program Ahonkhai, Aima A. Noubary, Farzad Munro, Alison Stark, Ruth Wilke, Marisa Freedberg, Kenneth A. Wood, Robin Losina, Elena PLoS One Research Article BACKGROUND: Many HIV treatment programs in resource-limited settings are plagued by high rates of loss to follow-up (LTFU). Most studies have not distinguished between those who briefly interrupt, but return to care, and those more chronically lost to follow-up. METHODS: We conducted a retrospective cohort study of 11,397 adults initiating antiretroviral therapy (ART) in 71 Southern African Catholic Bishops Conference/Catholic Relief Services HIV treatment clinics between January 2004 and December 2008. We distinguished among patients with early death, within the first 7 months on ART; patients with interruptions in laboratory monitoring (ILM), defined as missing visits in the first 7 months on ART, but returning to care by 12 months; and those LTFU, defined as missing all follow-up visits in the first 12 months on ART. We used multilevel logistic regression models to determine patient and clinic-level characteristics associated with these outcomes. RESULTS: In the first year on ART, 60% of patients remained in care, 30% missed laboratory visits, and 10% suffered early death. Of the 3,194 patients who missed laboratory visits, 40% had ILM, resuming care by 12 months. After 12 months on ART, patients with ILM had a 30% increase in detectable viremia compared to those who remained in care. Risk of LTFU decreased with increasing enrollment year, and was lowest for patients who enrolled in 2008 compared to 2004 [OR 0.49, 95%CI 0.39–0.62]. CONCLUSIONS: In a large community-based cohort in South Africa, nearly 30% of patients miss follow-up visits for CD4 monitoring in the first year after starting ART. Of those, 40% have ILM but return to clinic with worse virologic outcomes than those who remain in care. The risk of chronic LTFU decreased with enrollment year. As ART availability increases, interruptions in care may become more common, and should be accounted for in addressing program LTFU. Public Library of Science 2012-03-12 /pmc/articles/PMC3299719/ /pubmed/22427925 http://dx.doi.org/10.1371/journal.pone.0032993 Text en Ahonkhai et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Ahonkhai, Aima A. Noubary, Farzad Munro, Alison Stark, Ruth Wilke, Marisa Freedberg, Kenneth A. Wood, Robin Losina, Elena Not All Are Lost: Interrupted Laboratory Monitoring, Early Death, and Loss to Follow-Up (LTFU) in a Large South African Treatment Program |
title | Not All Are Lost: Interrupted Laboratory Monitoring, Early Death, and Loss to Follow-Up (LTFU) in a Large South African Treatment Program |
title_full | Not All Are Lost: Interrupted Laboratory Monitoring, Early Death, and Loss to Follow-Up (LTFU) in a Large South African Treatment Program |
title_fullStr | Not All Are Lost: Interrupted Laboratory Monitoring, Early Death, and Loss to Follow-Up (LTFU) in a Large South African Treatment Program |
title_full_unstemmed | Not All Are Lost: Interrupted Laboratory Monitoring, Early Death, and Loss to Follow-Up (LTFU) in a Large South African Treatment Program |
title_short | Not All Are Lost: Interrupted Laboratory Monitoring, Early Death, and Loss to Follow-Up (LTFU) in a Large South African Treatment Program |
title_sort | not all are lost: interrupted laboratory monitoring, early death, and loss to follow-up (ltfu) in a large south african treatment program |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3299719/ https://www.ncbi.nlm.nih.gov/pubmed/22427925 http://dx.doi.org/10.1371/journal.pone.0032993 |
work_keys_str_mv | AT ahonkhaiaimaa notallarelostinterruptedlaboratorymonitoringearlydeathandlosstofollowupltfuinalargesouthafricantreatmentprogram AT noubaryfarzad notallarelostinterruptedlaboratorymonitoringearlydeathandlosstofollowupltfuinalargesouthafricantreatmentprogram AT munroalison notallarelostinterruptedlaboratorymonitoringearlydeathandlosstofollowupltfuinalargesouthafricantreatmentprogram AT starkruth notallarelostinterruptedlaboratorymonitoringearlydeathandlosstofollowupltfuinalargesouthafricantreatmentprogram AT wilkemarisa notallarelostinterruptedlaboratorymonitoringearlydeathandlosstofollowupltfuinalargesouthafricantreatmentprogram AT freedbergkennetha notallarelostinterruptedlaboratorymonitoringearlydeathandlosstofollowupltfuinalargesouthafricantreatmentprogram AT woodrobin notallarelostinterruptedlaboratorymonitoringearlydeathandlosstofollowupltfuinalargesouthafricantreatmentprogram AT losinaelena notallarelostinterruptedlaboratorymonitoringearlydeathandlosstofollowupltfuinalargesouthafricantreatmentprogram |